Perceptions of Quality‐of‐Life Effects of Treatments for Diabetes Mellitus in Vulnerable and Nonvulnerable Older Patients
- 1 July 2008
- journal article
- research article
- Published by Wiley in Journal of the American Geriatrics Society
- Vol. 56 (7), 1183-1190
- https://doi.org/10.1111/j.1532-5415.2008.01757.x
Abstract
OBJECTIVES: To assess whether patient perceptions of treatments for diabetes mellitus differ according to clinical criteria such as limited life expectancy and functional decline (i.e., vulnerability). DESIGN: Cross‐sectional survey. SETTING: Clinics affiliated with two Chicago‐area hospitals. PARTICIPANTS: Patients aged 65 and older living with type 2 diabetes mellitus (N=332). MEASUREMENTS: Utilities (quantitative measures of preference on a scale from 0 to 1, with 0 representing a state equivalent to death and 1 representing life in perfect health) were assessed for nine hypothetical treatment states using time trade‐off questions, and patients were queried about specific concerns regarding medications. Vulnerability was defined according to the Vulnerable Elders Scale. RESULTS: Thirty‐six percent of patients were vulnerable. Vulnerable patients were older (77 vs 73) and had diabetes mellitus longer (13 vs 10 years; P<.05). Vulnerable patients reported lower utilities than nonvulnerable patients for most individual treatment states (e.g., intensive glucose control, mean 0.61 vs 0.72, P<.01), but within group variation was large for both groups (e.g., standard deviations >0.25). Although mean individual state utilities differed across groups, no significant differences were found in how vulnerable and nonvulnerable patients compared intensive and conventional treatment states (e.g., intensive vs conventional glucose control). In multivariable analyses, the association between vulnerability and individual treatment state utilities became nonsignificant except for the cholesterol pill. CONCLUSION: Older patients' preferences for intensity of treatment for diabetes mellitus vary widely and are not closely associated with vulnerability. This observation underscores the importance of involving older patients in decisions about treatment for diabetes mellitus, irrespective of clinical status.Keywords
This publication has 46 references indexed in Scilit:
- Race/Ethnicity and Economic Differences in Cost-Related Medication Underuse Among Insured Adults With DiabetesDiabetes Care, 2008
- Pay for Performance at the Tipping PointNew England Journal of Medicine, 2007
- Implications of New Geriatric Diabetes Care Guidelines for the Assessment of Quality of Care in Older PatientsMedical Care, 2006
- Mild Cognitive Impairment and Functional StatusJournal of the American Geriatrics Society, 2005
- Clinical Practice Guidelines and Quality of Care for Older Patients With Multiple Comorbid DiseasesJAMA, 2005
- Executive Control Mediates Memory's Association with Change in Instrumental Activities of Daily Living: The Freedom House StudyJournal of the American Geriatrics Society, 2004
- Practical Challenges of Individualizing Diabetes Care in Older PatientsThe Diabetes Educator, 2004
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987